Sunday, June 23, 2024
Hawai'i Free Press

Current Articles | Archives

Friday, October 6, 2017
RU486: ACLU Chooses Hawaii to Launch Abortion Drug Litigation
By Selected News Articles @ 11:43 AM :: 5842 Views :: Health Care, Life

ACLU Fights Federal Limits on Access to Abortion Drug

by Nicholas Fillmore, CourtHouse News October 5, 2017

HONOLULU (CN) – The American Civil Liberties Union of Hawaii filed a federal lawsuit against the Food and Drug Administration over federal restrictions that limit access to an abortion pill.

The abortion pill Mifeprex, also called RU-486, currently cannot be obtained at a retail pharmacy. Instead, a prescription for the pill must be obtained from a clinic, medical office or hospital that has registered with the manufacturer.

In addition, a woman seeking the pill must sign a patient agreement attesting that she has received counseling on the risks associated with Mifeprex, according to a lawsuit filed Tuesday by ACLU attorneys.

The complaint, filed in Hawaii federal court on behalf of a Kauai doctor and several health care providers, claims the FDA subjects Mifeprex to a Risk Evaluation and Mitigation Strategy, or REMS, process that burdens medical providers and limits patient access to the pill.

The FDA imposes restrictions on access to the drug despite its own finding in March 2016 that serious adverse events associated with Mifeprex are “exceedingly rare,” the lawsuit states.

The ACLU says the REMS process violates the U.S. Supreme Court’s 2016 decision in Whole Woman’s Health v. Hellerstedt, which found that health care regulations must serve patient health and cannot limit access to abortion without a valid medical reason.

“The unique and harmful restrictions the FDA imposes on where and how a patient may receive Mifeprex deny women meaningful access to this safe and effective treatment with no medical justification,” the complaint says.

Risks associated with Mifeprex are lower than those of common medications such as Viagra or blood thinners, according to the ACLU, and the risk of fatality is 14 times greater for a woman who carries a pregnancy to term than for a woman who uses Mifeprex.

Since the drug’s approval in 2000, about 3 million women in the United States have used Mifeprex to end an early pregnancy, the complaint states.

Lead plaintiff Dr. Graham Chelius, chief medical officer with the Hawaii Health Systems Corporation on the island of Kauai, laments that he is unable to comply with medically unnecessary requirements. Specifically, he said he is unable to stock the abortion pill on site because of opposition to abortion by co-workers.

According to the ACLU’s lawsuit, because of the Mifeprex REMS, the process for stocking the drug can be delayed or derailed altogether by a single individual with influence over a health care facility’s procurement procedure.

“Because I can’t stock this medication, my patients are forced to fly to a different island, 150 miles away, just to get a pill or any other kind of abortion care,” Chelius said in a blog post, “making this trip is a real challenge for my patients, many of whom don’t have a lot of money.”

Julia Kaye, staff attorney with the ACLU Reproductive Freedom Project, said in a statement that the “abortion pill is safe, effective, and legal.”

“So why is the FDA keeping it locked away from women who need it?” she said. “The FDA’s unique restrictions on medication abortion are not grounded in science — this is just abortion stigma made law.”

The FDA has said it does not comment on pending litigation and confirmed this week that its position on Mifeprex has not changed since the agency issued the new guidelines last year, according to reports.

Chelius and his co-plaintiffs are represented by lead attorney Mateo Caballero with the ACLU of Hawaii. 


CT: ACLU files lawsuit to challenge FDA regulation that ban sales of abortion pills in pharmacies   

AP: Arkansas and Hawaii Medication Abortion Cases Present New Challenges

ONN: Lawsuit seeks to make abortion drugs easier to obtain


TEXT "follow HawaiiFreePress" to 40404

Register to Vote


Aloha Pregnancy Care Center


Antonio Gramsci Reading List

A Place for Women in Waipio

Ballotpedia Hawaii

Broken Trust

Build More Hawaiian Homes Working Group

Christian Homeschoolers of Hawaii

Cliff Slater's Second Opinion

DVids Hawaii


Fix Oahu!

Frontline: The Fixers

Genetic Literacy Project

Grassroot Institute

Hawaii Aquarium Fish Report

Hawaii Aviation Preservation Society

Hawaii Catholic TV

Hawaii Christian Coalition

Hawaii Cigar Association

Hawaii ConCon Info

Hawaii Debt Clock

Hawaii Defense Foundation

Hawaii Family Forum

Hawaii Farmers and Ranchers United

Hawaii Farmer's Daughter

Hawaii Federation of Republican Women

Hawaii History Blog

Hawaii Jihadi Trial

Hawaii Legal News

Hawaii Legal Short-Term Rental Alliance

Hawaii Matters

Hawaii Military History

Hawaii's Partnership for Appropriate & Compassionate Care

Hawaii Public Charter School Network

Hawaii Rifle Association

Hawaii Shippers Council

Hawaii Together


Hiram Fong Papers

Homeschool Legal Defense Hawaii

Honolulu Navy League

Honolulu Traffic

House Minority Blog

Imua TMT

Inouye-Kwock, NYT 1992

Inside the Nature Conservancy

Inverse Condemnation

July 4 in Hawaii

Land and Power in Hawaii

Lessons in Firearm Education

Lingle Years

Managed Care Matters -- Hawaii

Missile Defense Advocacy

MIS Veterans Hawaii

NAMI Hawaii

National Parents Org Hawaii

NFIB Hawaii News

NRA-ILA Hawaii


OHA Lies

Opt Out Today

Patients Rights Council Hawaii

Practical Policy Institute of Hawaii

Pritchett Cartoons

Pro-GMO Hawaii

Rental by Owner Awareness Assn

Research Institute for Hawaii USA

Rick Hamada Show

RJ Rummel

School Choice in Hawaii

Talking Tax

Tax Foundation of Hawaii

The Real Hanabusa

Time Out Honolulu

Trustee Akina KWO Columns

West Maui Taxpayers Association

What Natalie Thinks

Whole Life Hawaii